hormone prostate treatment



Hormone therapy

Hormones control the growth and activity of body cells. Testosterone is the major male hormone that occurs naturally in the body. Hormones act like a fuel to feed the cancer cells and keep them active. By consequence, prostate cancer cells depend of these hormones.

Hormone therapy acts by lowering the testosterone being made in your body. The purpose of this type of therapy is twofold:
  1. Delay the cancer’s progression and
  2. Maximize the quality of life.
Because prostate cancer depend of these hormones, when the amount of testosterone is reduced, it is possible to slow down or shrink the tumor. Sometimes the symptoms disappear completely.

Also known as androgen deprivation therapy, hormone therapy can be used by itself or in combination with radiation therapy or surgery (radical prostatectomy) to treat prostate cancer. What treatment is recommended for you, will depend on if the tumor has spread outside the prostate gland.

How testosterone leve is reduced

testosterone prostate treatment The testosterone levels can be reduced either by surgery or drugs. As testosterone is mainly made in the testes, surgery means castration and it is performed in advanced stages when cancer has spread to the bone and is affecting the spinal cord.

These days, patients are more likely to have drug based hormone treatment than surgery. For this, here are two main types of drugs called Pituitary down regulators and Anti androgens

Usually patients have either an anti androgen or a pituitary down regulator. But they may have them together for a short time to if the doctor wants to prevent tumor flare or if cancer is showing signs of becoming resistant to one of the drugs taken on its own. Pituitary down regulators are generally thought to be more effective, but high dose of anti androgens is also sometimes used for locally advanced prostate cancer (stage 3).

When is hormone therapy prescribed?

When the tumor is localized in prostate it is successfully treated with surgery. When cancer cells migrate in the body, hormone therapy is more effective. Patients with very early prostate cancer that can be cured with radiotherapy or surgery, won't need hormone therapy if they are not at high risk for recurrence.

Hormone therapy is prescribed only after surgery because having it beforehand can make more technically difficult for your surgeon to get the cancer out.

When cancer is potentially curable, patients may have hormone therapy for a few months before radical radiotherapy. Most doctors will also recommend patients to have some hormone therapy together with radiotherapy treatment. The exact treatment will depend on stage and grade of cancer, age and general health of patients.

Side effects of hormone therapy

Testosterone plays a significant role in establishing and maintaining the typical male characteristics. Because loss of testosterone can alter man lifestyle, the patient should have a discussion regarding the effects of hormone therapy before beginning it.

The degree to which any man will be affected by testosterone loss is very hard to predict, but the patients must know that the list of potential effects is long: hot flashes, erectile dysfunction, decreased sexual desire, decreased muscle mass, fatigue, anemia, osteoporosis, weight gain and memory loss.

Latest News

  • New approach regarding androgen deprivation therapy
    There is an increasing belief among at least some opinion-leaders in the prostate cancer treatment community that androgen deprivation therapy (ADT) has been and still is being significantly overused. [ read full article ]

  • Hormone therapy makes prostate tumour becoming more aggressive and more liable to form metastases
    One of the conclusion of a thesis presented at the Sahlgrenska Academy, University of Gothenburg, Sweden, shows that hormone therapy is often given to patients with advanced prostate cancer. [ read full article ]

  • Anxiety leads to early use of androgen deprivation therapy
    A recent study has concluded that cancer anxiety independently and robustly predicts earlier androgen deprivation therapy (ADT) initiation in older men with biochemical recurrence. They note, however, that among older patients with prostate cancer, earlier initiation of ADT may have limited impact on life expectancy and can negatively impact patients’ health-related quality of life. [ read full article ]

  • Abiraterone shows promissing results
    Studies have revealed that prostate cancer grows when exposed to the male hormone testosterone and its related hormones, called androgens. For this reason, hormone treatment is given to halt the production of testosterone and androgens. [ read full article ]

  • Why prostate cancer patients fail hormone deprivation therapy
    The hormone deprivation therapy that prostate cancer patients often take gives them only a temporary fix, with tumors usually regaining their hold within a couple of years. Now, researchers at Johns Hopkins have discovered critical differences in the hormone receptors on prostate cancer cells in patients who no longer respond to this therapy. [ read full article ]

  • Hormone Therapy Not Best for Older Prostate Cancer Patients
    Older men with early-stage prostate cancer who are given hormone therapy before radiation seed implant therapy face a 20 percent greater risk of dying than those who get radiation treatment alone, new research suggests. [ read full article ]

  • Drug Can Slow Bone Loss in Prostate Cancer Patients
    Men receiving hormone-deprivation therapy for advanced but localized prostate cancer can develop bone loss as a side effect of the treatment. [ read full article ]

  • Testosterone Activates Similar Genes In Prostate Development And Prostate Cancer
    Gene activity in prostate cancer is reminiscent of that in the developing fetal prostate, providing further evidence that all cancers are not equal, Johns Hopkins researchers report. The finding could help scientists investigate how to manipulate the genetic program [ read full article ]

  • Study shows hormone therapy can speed prostate cancer
    University of Rochester researchers suggest that hormone therapy, the most common treatment for advanced prostate cancer, can boomerang to make the cancer more deadly. This conclusion is based on research on mice. [ read full article ]

  • Why hormone therapy for prostate cancer fails
    Some of the drugs given to many men during their fight against prostate cancer can actually spur some cancer cells to grow, researchers have found. The findings were published online this week in a pair of papers in the Proceedings of the National Academy of Sciences. [ read full article ]

  • Prostate Cancer Patients Undergoing Hormone Therapy May Experience Cognitive Effects
    A recent review of the literature has found that hormone deprivation therapy, a commonly used treatment for prostate cancer, may have subtle adverse effects on cognition in patients--such as in the ability to recall and concentrate. [ read full article ]

  • ED from prostate cancer hormone therapy treatable
    A new study shows that a substantial minority of men receiving so-called androgen deprivation therapy, or ADT, for prostate cancer experience erectile dysfunction (ED). However, many respond well to ED therapy, doctors from Memphis have found. [ read full article ]

  • Hormone Therapy Shows Little Benefit Against Prostate Cancer
    An increasingly common therapy used for localized prostate cancer may not bestow any survival benefits on the patient beyond those seen with a simple "wait-and-see" approach.
    [ read full article ]

  • Androgen deprivation therapy does not improve survival for elderly men with localized prostate cancer
    A therapy that involves depriving the prostate gland the male hormone androgen is not associated with improved survival for elderly men with localized prostate cancer, compared to conservative management of the disease, according to a study in the July 9 issue of JAMA, the Journal of the American Medical Association. [ read full article ]

  • Hormone therapy only helps some older men with prostate cancer
    Adding hormone therapy to radiation treatment for fast-moving prostate cancer can save lives, but the benefit often doesn't apply to men who have other serious medical problems [ read full article ]



    [ read more articles ]



    NOTE: Issues on this site regarding men's health and their concerns, are provided for information only, and are not meant to substitute for the advice of your own physician or other medical professional. Prostate-Report.org does not endorse any specific product, service or treatment.





  • Tell a Friend

    Your Name:
    Friend's Name:
    Friend's Email:
    copyright © 2009 | hormone therapy for cancer prostate treatment in patients with testosterone loss